文献速递慢阻肺

磨玻璃影与全身炎症及肺气肿进展的关联

Association of Ground-Glass Opacities with Systemic Inflammation and Progression of Emphysema.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

基于SPIROMICS队列2,714名参与者(1,680例COPD,1,034例正常肺功能),通过影像标注与AMFM量化磨玻璃影体积(%GGOAMFM)。在COPD患者中,%GGOAMFM与白细胞及中性粒细胞浓度横断面相关,且每增加一个四分位距与1年肺气肿相对增加11.7%相关,并与急性加重和全因死亡相关。

要点

  • %GGOAMFM与COPD患者全身炎症指标(WBC、中性粒细胞)横断面相关。
  • 基线%GGOAMFM每增一个四分位距,1年肺气肿相对增加11.7%。
  • %GGOAMFM与急性加重和全因死亡相关,但与1年FEV1下降无关。

核心结论

  • GGOAMFM与全身炎症增加及肺气肿进展相关。

研究设计与样本

  • SPIROMICS研究的事后分析,共纳入2,714名参与者,其中1,680例COPD和1,034例正常肺功能。
  • 由胸部放射科和呼吸科医生标注磨玻璃影区域,采用自适应多特征方法(AMFM)训练计算机量化%GGOAMFM。
  • 使用多变量线性回归、零膨胀负二项回归和比例风险回归模型分析关联。

主要发现

  • 在COPD患者中,当前吸烟和慢性咳痰与更高的%GGOAMFM相关。
  • %GGOAMFM与白细胞和中性粒细胞浓度横断面正相关。
  • 基线%GGOAMFM每增加一个四分位距,1年随访时肺气肿相对增加11.7%(95%CI 7.5-16.1%,P<0.001)。
  • %GGOAMFM与1年FEV1下降无关联,但与随访中位1,544天(四分位间期1,118-2,059)内的急性加重和全因死亡相关。
  • 在正常肺功能参与者中,除%GGOAMFM与1年随访进展为COPD相关外,其余结果类似。

临床怎么用

  • 在COPD患者中,可关注磨玻璃影的量化评估,其与全身炎症及肺气肿进展相关。
  • %GGOAMFM较高可能提示急性加重和死亡风险增加,但需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Ground-glass opacities (GGOs) in the absence of interstitial lung disease are understudied. Objectives: To assess the association of GGOs with white blood cells (WBCs) and progression of quantified chest computed tomography emphysema. Methods: We analyzed data of participants in the SPIROMICS study (Subpopulations and Intermediate Outcome Measures in COPD Study). Chest radiologists and pulmonologists labeled regions of the lung as GGOs, and the adaptive multiple feature method (AMFM) trained the computer to assign those labels to image voxels and quantify the volume of the lung with GGOs (%GGOAMFM). We used multivariable linear regression, zero-inflated negative binomial, and proportional hazards regression models to assess the association of %GGOAMFM with WBCs, changes in percentage emphysema, and clinical outcomes. Measurements and Main Results: Among 2,714 participants, 1,680 had chronic obstructive pulmonary disease (COPD) and 1,034 had normal spirometry. Among participants with COPD, on the basis of multivariable analysis, current smoking and chronic productive cough were associated with higher %GGOAMFM. Higher %GGOAMFM was cross-sectionally associated with higher WBC and neutrophil concentrations. Higher %GGOAMFM per interquartile range at visit 1 (baseline) was associated with an increase in emphysema at 1-year follow-up visit by 11.7% (relative increase; 95% confidence interval, 7.5-16.1%; P < 0.001). We found no association between %GGOAMFM and 1-year FEV1 decline, but %GGOAMFM was associated with exacerbations and all-cause mortality during a median follow-up of 1,544 days (interquartile interval, 1,118-2,059). Among normal spirometry participants, we found similar results, except that %GGOAMFM was associated with progression to COPD at 1-year follow-up. Conclusions: Our findings suggest that GGOAMFM is associated with increased systemic inflammation and emphysema progression.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Fortis S, Guo J, Nagpal P, et al. Association of Ground-Glass Opacities with Systemic Inflammation and Progression of Emphysema. Am J Respir Crit Care Med. 2024. PMID: 38843116. doi:10.1164/rccm.202310-1825OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。